Q32 Bio (QTTB) Property, Plant & Equipment (Net) Growth (1y) (2018 - 2026)
Q32 Bio (QTTB) Property, Plant & Equipment (Net) Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 58.66% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -10.19% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 2.65% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 24.11% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 12.18% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -95.71% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Q32 Bio | 215.94 Mn | 165.19 Mn | - | -28.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.94% |
| Dec 31, 2025 | -28.54% |
| Sep 30, 2025 | -28.16% |
| Jun 30, 2025 | -25.31% |
| Mar 31, 2025 | -24.59% |
| Dec 31, 2024 | -23.12% |
| Jun 30, 2024 | 83.79% |
| Mar 31, 2024 | 56.21% |
| Dec 31, 2023 | 65.31% |
| Jun 30, 2023 | -50.87% |
| Mar 31, 2023 | -46.53% |
| Dec 31, 2022 | -52.13% |
| Sep 30, 2022 | -95.67% |
| Jun 30, 2022 | -95.00% |
| Mar 31, 2022 | -94.51% |
| Dec 31, 2021 | -93.91% |
| Sep 30, 2021 | -17.61% |
| Jun 30, 2021 | -15.68% |
| Mar 31, 2021 | -15.07% |
| Dec 31, 2020 | -13.38% |